ArticleJournal of pancreatic cancer2020

A Phase I Study of Ribociclib Plus Everolimus in Patients with Metastatic Pancreatic Adenocarcinoma Refractory to Chemotherapy.

Benjamin A Weinberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.